查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1839188

治療診斷學市場分析及至2034年的預測：類型、產品、服務、技術、組件、應用、最終用戶、設備和流程

Theranostics Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, End User, Device, Process
出版日期: | 出版商: Global Insight Services | 英文 397 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到2034年，治療診斷學市場規模將從2024年的36億美元增加到118億美元，年複合成長率約為12.6%。治療診斷學市場透過將治療和診斷功能整合到單一平台，實現個人化治療策略。這種創新方法將標靶治療與影像學和生物標記相結合，以增強療效並監測治療反應。隨著精準醫療的日益普及，在分子成像、奈米技術和生物標記發現的推動下，治療診斷學有望顯著成長。癌症發生率的上升以及對個人化醫療解決方案的需求進一步推動了該市場的發展，為製藥和診斷行業的相關人員創造了巨大的商機。

預計治療診斷學市場將出現顯著成長，這主要歸功於個人化醫療中診斷和治療藥物的整合。放射性藥物引領市場，其中放射性同位素和放射性標記肽對於增強癌症的標靶治療非常重要。緊隨其後的是影像領域，包括 PET 和 SPECT 技術，突顯了它們在準確疾病診斷中的重要性。腫瘤學子領域表現最佳，這得益於癌症發生率上升和對標靶治療的需求。心血管治療診斷是第二大子領域，由於心臟病影像診斷技術的進步而獲得發展動力。製藥公司和診斷公司之間日益增多的合作加速該領域的技術創新。此外，人工智慧在影像和診斷中的整合提高治療診斷解決方案的準確性和效率。隨著患者和醫療保健提供者尋求更安全、更有效的治療方法，對微創手術的需求進一步推動了市場成長。

市場區隔
類型 影像劑、治療劑、放射性同位素、生物標記、奈米粒子、小分子、抗體、胜肽、基因治療
產品 套件、試劑、儀器、軟體、耗材、檢測系統、診斷設備、治療設備
服務 諮詢、維護、安裝、培訓、資料分析、遠端監控
技術 PCR、NGS、免疫檢測、質譜、微陣列、流式細胞技術、液態切片
組件 硬體、軟體和服務
用途 腫瘤科、神經科、循環系統、感染疾病科、內分泌科、胃腸科、呼吸科
最終用戶 醫院、診斷實驗室、研究機構、製藥公司、生技公司、學術機構
裝置 PET掃描儀、MRI掃描儀、CT掃描儀、超音波設備、伽馬攝影機
過程 體內、體外

市場概述

在創新定價策略和新產品推出激增的推動下，治療診斷學市場正經歷市場佔有率的動態變化。行業主要企業利用先進技術提供具有競爭力的價格，提高可及性和採用率。市場的特點是新產品不斷湧入，反映出強大的開發平臺，以滿足日益成長的個人化醫療需求。這一趨勢凸顯了該行業致力於整合治療和診斷能力，使其處於精準醫療的前沿。競爭基準基準化分析表明，策略聯盟和合併推動競爭優勢。監管影響巨大，嚴格的指導方針決定市場進入和產品開發。雖然市場環境由少數主要企業主導，但由創新和策略夥伴關係關係驅動的新興企業取得重大進展。北美和歐洲的法規結構尤其具有影響力，它們塑造著市場動態並創造了有利於成長的競爭環境。市場未來前景光明，技術進步和監管支援為持續擴張鋪平了道路。

主要趨勢和促進因素：

在個人化醫療和標靶治療的推動下，治療診斷學市場正經歷強勁成長。一個關鍵趨勢是整合診斷和治療能力，以提高治療的準確性和有效性。隨著醫療保健系統努力為患者提供更個人化的治療，這種方法越來越受到關注。癌症和心血管疾病等慢性疾病的日益普及是一個關鍵促進因素。這些疾病需要創新的治療方案，進一步推動了治療診斷學的應用。此外，診斷影像技術的進步提高診斷的準確性，實現更早的發現和早期療育。伴隨診斷的興起也是一個值得注意的趨勢，它支持個人化治療方法的發展。治療診斷產品監管核准的增加趨勢反映出人們對其潛力的信心日益增強。隨著醫療基礎設施的發展和對先進療法的需求的增加，新興市場提供了重大機會。投資研發的公司完全有能力利用這些不斷擴大的機會，並將自己定位為不斷發展的治療診斷學領域的領導者。

限制與挑戰：

治療診斷學市場面臨一些顯著的限制和挑戰。一個關鍵挑戰是整合診斷和治療技術的成本高昂，這給醫療服務提供者和患者帶來了經濟負擔。這種經濟障礙限制了該技術的可及性和採用率，尤其是在新興市場。監管複雜性也是一個重大挑戰。治療診斷產品複雜的核准流程可能會延遲市場進入並增加開發成本。此外，不同地區缺乏標準化的法律規範，進一步加劇了全球市場擴張的複雜性。另一個挑戰是醫療專業人員對治療治療診斷學的認知和理解有限。這種知識差距可能會阻礙這些技術在臨床環境中的有效實施，並限制潛在的效益。此外，該領域技術的快速進步需要持續的研發投入。這種需求給公司帶來了壓力，要求他們在管理財務永續性的同時進行創新。最後，治療診斷應用中與病患資訊相關的資料隱私問題構成了一大障礙。確保強力的資料保護措施對於贏得病患信任和遵守法規非常重要。

主要企業

Advanced Accelerator Applications、Theragnostics、Lantheus Holdings、NanoMab Technology、Radiomedix、Telix Pharmaceuticals、Blue Earth Diagnostics、Isotopia Molecular Imaging、Sofie Biosciences、Endocyte、Navidea Biopharmaceuticals、Cyclopharm、ImaginAb、OncoNano Medicine、Cerveau Technologies

目錄

第1章 治療診斷學市場概述

  • 調查目的
  • 治療診斷學市場定義和範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章 執行摘要

第3章 重要考察

第4章 治療診斷學市場展望

  • 治療診斷學市場區隔
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • ANSOFF矩陣

第5章 治療診斷學市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章 治療診斷學市場規模

  • 治療診斷學市場規模（依價值）
  • 治療診斷學市場規模（依數量）

第7章 治療診斷學市場（依類型）

  • 市場概況
  • 顯影劑
  • 治療藥物
  • 放射性同位素
  • 生物標記
  • 奈米粒子
  • 低分子
  • 抗體
  • 胜肽
  • 基因治療
  • 其他

第8章 治療診斷學市場（依產品）

  • 市場概況
  • 套件
  • 試劑
  • 裝置
  • 軟體
  • 耗材
  • 檢測系統
  • 診斷設備
  • 治療設備
  • 其他

第9章 治療診斷學市場（依服務）

  • 市場概況
  • 諮詢
  • 維護
  • 安裝
  • 訓練
  • 資料分析
  • 遠端監控
  • 其他

第10章 治療診斷學市場（依技術）

  • 市場概況
  • PCR
  • NGS
  • 免疫檢測
  • 質譜法
  • 微陣列
  • 流式細胞技術
  • 液態切片
  • 其他

第11章 治療診斷學市場：依組成部分

  • 市場概況
  • 硬體
  • 軟體
  • 服務
  • 其他

第12章 治療診斷學市場：依應用

  • 市場概況
  • 腫瘤學
  • 神經病學
  • 循環系統
  • 感染疾病
  • 內分泌學
  • 胃腸病學
  • 呼吸系統醫療設備
  • 其他

第13章 治療診斷學市場：依最終用戶

  • 市場概況
  • 醫院
  • 診斷實驗室
  • 研究所
  • 製藥公司
  • 生技公司
  • 學術機構
  • 其他

第14章 治療診斷學市場（依設備）

  • 市場概況
  • PET掃描儀
  • MRI掃描儀
  • CT掃描儀
  • 超音波設備
  • 伽馬攝影機
  • 其他

第15章 治療診斷學市場：依流程

  • 市場概況
  • 體內
  • 體外
  • 其他

第16章 治療診斷學市場（依地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第17章 競爭格局

  • 概述
  • 市場佔有率分析
  • 主要企業定位
  • 競爭領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第18章 公司簡介

  • Advanced Accelerator Applications
  • Theragnostics
  • Lantheus Holdings
  • NanoMab Technology
  • Radiomedix
  • Telix Pharmaceuticals
  • Blue Earth Diagnostics
  • Isotopia Molecular Imaging
  • Sofie Biosciences
  • Endocyte
  • Navidea Biopharmaceuticals
  • Cyclopharm
  • ImaginAb
  • OncoNano Medicine
  • Cerveau Technologies
簡介目錄
Product Code: GIS34343

Theranostics Market is anticipated to expand from $3.6 billion in 2024 to $11.8 billion by 2034, growing at a CAGR of approximately 12.6%. The Theranostics Market encompasses the integration of therapeutic and diagnostic capabilities within a single platform, enabling personalized treatment strategies. This innovative approach combines targeted therapies with diagnostic imaging or biomarkers to enhance treatment efficacy and monitor therapeutic responses. As precision medicine gains traction, theranostics is poised for significant growth, driven by advancements in molecular imaging, nanotechnology, and biomarker discovery. The market is further propelled by increasing cancer prevalence and the demand for tailored healthcare solutions, promising substantial opportunities for stakeholders in the pharmaceutical and diagnostic sectors.

The Theranostics Market is poised for substantial growth, primarily driven by the integration of diagnostics and therapeutics in personalized medicine. Radiopharmaceuticals lead the market, with radioisotopes and radiolabeled peptides being pivotal in enhancing targeted cancer treatment. The imaging segment, comprising PET and SPECT technologies, follows closely, underscoring their importance in precise disease diagnosis. The oncology sub-segment is the top performer, driven by the rising prevalence of cancer and the need for targeted therapies. Cardiovascular theranostics, as the second highest performing sub-segment, is gaining momentum due to advancements in imaging agents for heart disease. Increasing collaboration between pharmaceutical companies and diagnostic firms is accelerating innovation in this field. Additionally, the integration of artificial intelligence in imaging and diagnostics is enhancing the accuracy and efficiency of theranostic solutions. The demand for minimally invasive procedures is further propelling market growth, as patients and healthcare providers seek safer and more effective treatment options.

Market Segmentation
TypeImaging Agents, Therapeutic Agents, Radioisotopes, Biomarkers, Nanoparticles, Small Molecules, Antibodies, Peptides, Gene Therapy
ProductKits, Reagents, Instruments, Software, Consumables, Assay Systems, Diagnostic Devices, Therapeutic Devices
ServicesConsultation, Maintenance, Installation, Training, Data Analysis, Remote Monitoring
TechnologyPCR, NGS, Immunoassays, Mass Spectrometry, Microarrays, Flow Cytometry, Liquid Biopsies
ComponentHardware, Software, Services
ApplicationOncology, Neurology, Cardiology, Infectious Diseases, Endocrinology, Gastroenterology, Respiratory
End UserHospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Academic Institutions
DevicePET Scanners, MRI Scanners, CT Scanners, Ultrasound Devices, Gamma Cameras
ProcessIn Vivo, In Vitro

Market Snapshot:

The Theranostics market is witnessing a dynamic shift in market share, driven by innovative pricing strategies and a surge in new product launches. Key industry players are leveraging advanced technologies to offer competitive pricing, enhancing accessibility and adoption. The market is characterized by a continuous influx of novel products, reflecting a robust pipeline of developments aimed at meeting the growing demand for personalized medicine. This trend underscores the industry's commitment to integrating therapeutic and diagnostic capabilities, positioning itself at the forefront of precision healthcare. Competition benchmarking reveals a landscape marked by strategic alliances and mergers, enhancing competitive advantage. Regulatory influences are pivotal, with stringent guidelines shaping market entry and product development. The landscape is dominated by a few key players, yet emerging companies are making significant inroads, driven by innovation and strategic partnerships. Regulatory frameworks in North America and Europe are particularly influential, dictating market dynamics and fostering a competitive environment ripe for growth. The market's future is promising, with technological advancements and regulatory support paving the way for continued expansion.

Geographical Overview:

The theranostics market is witnessing notable expansion across various regions, each exhibiting unique growth dynamics. North America is at the forefront, driven by advanced healthcare infrastructure and significant investments in personalized medicine. The region's focus on integrating diagnostics and therapeutics enhances its market leadership. Europe follows closely, with strong regulatory support and a growing emphasis on precision medicine fostering a conducive environment for theranostics. Asia Pacific is rapidly emerging as a lucrative market, propelled by substantial investments in healthcare and technological advancements. Countries like China and India are spearheading growth, driven by increasing healthcare expenditures and a rising demand for personalized treatment solutions. Latin America and the Middle East & Africa are also showing promising growth potential. In Latin America, improving healthcare infrastructure and rising awareness of personalized medicine are key drivers. Meanwhile, the Middle East & Africa are recognizing the value of theranostics in addressing regional healthcare challenges and improving patient outcomes.

Key Trends and Drivers:

The theranostics market is experiencing robust growth, propelled by advancements in personalized medicine and targeted therapies. A key trend is the integration of diagnostic and therapeutic capabilities, which enhances treatment precision and efficacy. This approach is gaining traction as healthcare systems aim to provide more tailored patient care. Increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, is a significant driver. These conditions necessitate innovative treatment solutions, further fueling theranostics adoption. Additionally, advancements in imaging technologies are enhancing diagnostic accuracy, enabling early detection and intervention. The rise of companion diagnostics is another notable trend, supporting the development of personalized treatment regimens. Regulatory bodies are increasingly approving theranostic products, reflecting growing confidence in their potential. Emerging markets present lucrative opportunities as healthcare infrastructure improves and demand for advanced treatments rises. Companies investing in research and development are poised to capitalize on these expanding opportunities, positioning themselves as leaders in the evolving theranostics landscape.

Restraints and Challenges:

The Theranostics Market encounters several notable restraints and challenges. A primary challenge is the substantial cost associated with integrating diagnostic and therapeutic technologies, which imposes financial burdens on healthcare providers and patients alike. This financial barrier limits accessibility and adoption, particularly in emerging markets. Regulatory complexities also pose significant challenges. Navigating the intricate approval processes for theranostic products can delay market entry and increase development costs. Moreover, the lack of standardized regulatory frameworks across different regions further complicates global market expansion. Another challenge is the limited awareness and understanding of theranostics among healthcare professionals. This knowledge gap can impede the effective implementation of these technologies in clinical settings, restricting their potential benefits. Additionally, the rapid pace of technological advancements in the field requires continuous investment in research and development. This necessity places pressure on companies to innovate while managing financial sustainability. Lastly, data privacy concerns related to patient information in theranostic applications present a significant hurdle. Ensuring robust data protection measures is crucial to gaining patient trust and regulatory compliance.

Key Players:

Advanced Accelerator Applications, Theragnostics, Lantheus Holdings, NanoMab Technology, Radiomedix, Telix Pharmaceuticals, Blue Earth Diagnostics, Isotopia Molecular Imaging, Sofie Biosciences, Endocyte, Navidea Biopharmaceuticals, Cyclopharm, ImaginAb, OncoNano Medicine, Cerveau Technologies

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Theranostics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Theranostics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by End User
  • 2.10 Key Highlights of the Market, by Device
  • 2.11 Key Highlights of the Market, by Process
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by End User
  • 3.9 Market Attractiveness Analysis, by Device
  • 3.10 Market Attractiveness Analysis, by Process
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Theranostics Market Outlook

  • 4.1 Theranostics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Theranostics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Theranostics Market Size

  • 6.1 Theranostics Market Size, by Value
  • 6.2 Theranostics Market Size, by Volume

7: Theranostics Market, by Type

  • 7.1 Market Overview
  • 7.2 Imaging Agents
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutic Agents
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Radioisotopes
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Biomarkers
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Nanoparticles
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Small Molecules
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Antibodies
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Peptides
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Gene Therapy
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region
  • 7.11 Others
    • 7.11.1 Key Market Trends & Opportunity Analysis
    • 7.11.2 Market Size and Forecast, by Region

8: Theranostics Market, by Product

  • 8.1 Market Overview
  • 8.2 Kits
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Reagents
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Instruments
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Software
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Consumables
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Assay Systems
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Diagnostic Devices
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Therapeutic Devices
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Others
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region

9: Theranostics Market, by Services

  • 9.1 Market Overview
  • 9.2 Consultation
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Maintenance
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Installation
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Training
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Data Analysis
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Remote Monitoring
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Theranostics Market, by Technology

  • 10.1 Market Overview
  • 10.2 PCR
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 NGS
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Immunoassays
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Mass Spectrometry
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Microarrays
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Flow Cytometry
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Liquid Biopsies
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region
  • 10.9 Others
    • 10.9.1 Key Market Trends & Opportunity Analysis
    • 10.9.2 Market Size and Forecast, by Region

11: Theranostics Market, by Component

  • 11.1 Market Overview
  • 11.2 Hardware
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Software
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Services
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Theranostics Market, by Application

  • 12.1 Market Overview
  • 12.2 Oncology
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Neurology
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Cardiology
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Infectious Diseases
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Endocrinology
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Gastroenterology
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region
  • 12.8 Respiratory
    • 12.8.1 Key Market Trends & Opportunity Analysis
    • 12.8.2 Market Size and Forecast, by Region
  • 12.9 Others
    • 12.9.1 Key Market Trends & Opportunity Analysis
    • 12.9.2 Market Size and Forecast, by Region

13: Theranostics Market, by End User

  • 13.1 Market Overview
  • 13.2 Hospitals
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Diagnostic Laboratories
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Research Institutes
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Pharmaceutical Companies
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Biotechnology Companies
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Academic Institutions
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region
  • 13.8 Others
    • 13.8.1 Key Market Trends & Opportunity Analysis
    • 13.8.2 Market Size and Forecast, by Region

14: Theranostics Market, by Device

  • 14.1 Market Overview
  • 14.2 PET Scanners
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 MRI Scanners
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 CT Scanners
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Ultrasound Devices
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Gamma Cameras
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Others
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region

15: Theranostics Market, by Process

  • 15.1 Market Overview
  • 15.2 In Vivo
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 In Vitro
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Theranostics Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Component
    • 16.2.7 North America Market Size and Forecast, by Application
    • 16.2.8 North America Market Size and Forecast, by End User
    • 16.2.9 North America Market Size and Forecast, by Device
    • 16.2.10 North America Market Size and Forecast, by Process
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Component
      • 16.2.9.6 United States Market Size and Forecast, by Application
      • 16.2.9.7 United States Market Size and Forecast, by End User
      • 16.2.9.8 United States Market Size and Forecast, by Device
      • 16.2.9.9 United States Market Size and Forecast, by Process
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Component
      • 16.2.10.6 Canada Market Size and Forecast, by Application
      • 16.2.10.7 Canada Market Size and Forecast, by End User
      • 16.2.10.8 Canada Market Size and Forecast, by Device
      • 16.2.10.9 Canada Market Size and Forecast, by Process
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Component
    • 16.3.7 Europe Market Size and Forecast, by Application
    • 16.3.8 Europe Market Size and Forecast, by End User
    • 16.3.9 Europe Market Size and Forecast, by Device
    • 16.3.10 Europe Market Size and Forecast, by Process
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.7 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Component
      • 16.3.10.6 Germany Market Size and Forecast, by Application
      • 16.3.10.7 Germany Market Size and Forecast, by End User
      • 16.3.10.8 Germany Market Size and Forecast, by Device
      • 16.3.10.9 Germany Market Size and Forecast, by Process
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Component
      • 16.3.11.6 France Market Size and Forecast, by Application
      • 16.3.11.7 France Market Size and Forecast, by End User
      • 16.3.11.8 France Market Size and Forecast, by Device
      • 16.3.11.9 France Market Size and Forecast, by Process
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Component
      • 16.3.12.6 Spain Market Size and Forecast, by Application
      • 16.3.12.7 Spain Market Size and Forecast, by End User
      • 16.3.12.8 Spain Market Size and Forecast, by Device
      • 16.3.12.9 Spain Market Size and Forecast, by Process
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Component
      • 16.3.13.6 Italy Market Size and Forecast, by Application
      • 16.3.13.7 Italy Market Size and Forecast, by End User
      • 16.3.13.8 Italy Market Size and Forecast, by Device
      • 16.3.13.9 Italy Market Size and Forecast, by Process
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Component
      • 16.3.14.6 Netherlands Market Size and Forecast, by Application
      • 16.3.14.7 Netherlands Market Size and Forecast, by End User
      • 16.3.14.8 Netherlands Market Size and Forecast, by Device
      • 16.3.14.9 Netherlands Market Size and Forecast, by Process
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Component
      • 16.3.15.6 Sweden Market Size and Forecast, by Application
      • 16.3.15.7 Sweden Market Size and Forecast, by End User
      • 16.3.15.8 Sweden Market Size and Forecast, by Device
      • 16.3.15.9 Sweden Market Size and Forecast, by Process
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Component
      • 16.3.16.6 Switzerland Market Size and Forecast, by Application
      • 16.3.16.7 Switzerland Market Size and Forecast, by End User
      • 16.3.16.8 Switzerland Market Size and Forecast, by Device
      • 16.3.16.9 Switzerland Market Size and Forecast, by Process
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Component
      • 16.3.17.6 Denmark Market Size and Forecast, by Application
      • 16.3.17.7 Denmark Market Size and Forecast, by End User
      • 16.3.17.8 Denmark Market Size and Forecast, by Device
      • 16.3.17.9 Denmark Market Size and Forecast, by Process
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Component
      • 16.3.18.6 Finland Market Size and Forecast, by Application
      • 16.3.18.7 Finland Market Size and Forecast, by End User
      • 16.3.18.8 Finland Market Size and Forecast, by Device
      • 16.3.18.9 Finland Market Size and Forecast, by Process
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Component
      • 16.3.19.6 Russia Market Size and Forecast, by Application
      • 16.3.19.7 Russia Market Size and Forecast, by End User
      • 16.3.19.8 Russia Market Size and Forecast, by Device
      • 16.3.19.9 Russia Market Size and Forecast, by Process
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.8 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Component
      • 16.4.9.6 China Market Size and Forecast, by Application
      • 16.4.9.7 China Market Size and Forecast, by End User
      • 16.4.9.8 China Market Size and Forecast, by Device
      • 16.4.9.9 China Market Size and Forecast, by Process
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Component
      • 16.4.10.6 India Market Size and Forecast, by Application
      • 16.4.10.7 India Market Size and Forecast, by End User
      • 16.4.10.8 India Market Size and Forecast, by Device
      • 16.4.10.9 India Market Size and Forecast, by Process
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Component
      • 16.4.11.6 Japan Market Size and Forecast, by Application
      • 16.4.11.7 Japan Market Size and Forecast, by End User
      • 16.4.11.8 Japan Market Size and Forecast, by Device
      • 16.4.11.9 Japan Market Size and Forecast, by Process
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Component
      • 16.4.12.6 South Korea Market Size and Forecast, by Application
      • 16.4.12.7 South Korea Market Size and Forecast, by End User
      • 16.4.12.8 South Korea Market Size and Forecast, by Device
      • 16.4.12.9 South Korea Market Size and Forecast, by Process
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Component
      • 16.4.13.6 Australia Market Size and Forecast, by Application
      • 16.4.13.7 Australia Market Size and Forecast, by End User
      • 16.4.13.8 Australia Market Size and Forecast, by Device
      • 16.4.13.9 Australia Market Size and Forecast, by Process
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Component
      • 16.4.14.6 Singapore Market Size and Forecast, by Application
      • 16.4.14.7 Singapore Market Size and Forecast, by End User
      • 16.4.14.8 Singapore Market Size and Forecast, by Device
      • 16.4.14.9 Singapore Market Size and Forecast, by Process
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Component
      • 16.4.15.6 Indonesia Market Size and Forecast, by Application
      • 16.4.15.7 Indonesia Market Size and Forecast, by End User
      • 16.4.15.8 Indonesia Market Size and Forecast, by Device
      • 16.4.15.9 Indonesia Market Size and Forecast, by Process
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Component
      • 16.4.16.6 Taiwan Market Size and Forecast, by Application
      • 16.4.16.7 Taiwan Market Size and Forecast, by End User
      • 16.4.16.8 Taiwan Market Size and Forecast, by Device
      • 16.4.16.9 Taiwan Market Size and Forecast, by Process
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Component
      • 16.4.17.6 Malaysia Market Size and Forecast, by Application
      • 16.4.17.7 Malaysia Market Size and Forecast, by End User
      • 16.4.17.8 Malaysia Market Size and Forecast, by Device
      • 16.4.17.9 Malaysia Market Size and Forecast, by Process
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Component
    • 16.5.7 Latin America Market Size and Forecast, by Application
    • 16.5.8 Latin America Market Size and Forecast, by End User
    • 16.5.9 Latin America Market Size and Forecast, by Device
    • 16.5.10 Latin America Market Size and Forecast, by Process
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Component
      • 16.5.9.6 Brazil Market Size and Forecast, by Application
      • 16.5.9.7 Brazil Market Size and Forecast, by End User
      • 16.5.9.8 Brazil Market Size and Forecast, by Device
      • 16.5.9.9 Brazil Market Size and Forecast, by Process
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Component
      • 16.5.10.6 Mexico Market Size and Forecast, by Application
      • 16.5.10.7 Mexico Market Size and Forecast, by End User
      • 16.5.10.8 Mexico Market Size and Forecast, by Device
      • 16.5.10.9 Mexico Market Size and Forecast, by Process
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Component
      • 16.5.11.6 Argentina Market Size and Forecast, by Application
      • 16.5.11.7 Argentina Market Size and Forecast, by End User
      • 16.5.11.8 Argentina Market Size and Forecast, by Device
      • 16.5.11.9 Argentina Market Size and Forecast, by Process
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.8 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Component
      • 16.6.10.6 UAE Market Size and Forecast, by Application
      • 16.6.10.7 UAE Market Size and Forecast, by End User
      • 16.6.10.8 UAE Market Size and Forecast, by Device
      • 16.6.10.9 UAE Market Size and Forecast, by Process
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Component
      • 16.6.11.6 South Africa Market Size and Forecast, by Application
      • 16.6.11.7 South Africa Market Size and Forecast, by End User
      • 16.6.11.8 South Africa Market Size and Forecast, by Device
      • 16.6.11.9 South Africa Market Size and Forecast, by Process
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Advanced Accelerator Applications
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Theragnostics
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Lantheus Holdings
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 NanoMab Technology
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Radiomedix
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Telix Pharmaceuticals
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Blue Earth Diagnostics
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Isotopia Molecular Imaging
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Sofie Biosciences
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Endocyte
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Navidea Biopharmaceuticals
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Cyclopharm
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 ImaginAb
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 OncoNano Medicine
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Cerveau Technologies
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis